Programa de Pós-Graduação em Química Medicinal e Modelagem Molecular - PPGQMMM/ICS
URI Permanente desta comunidadehttps://repositorio.ufpa.br/handle/2011/14430
Navegar
Navegando Programa de Pós-Graduação em Química Medicinal e Modelagem Molecular - PPGQMMM/ICS por Orientadores "CALCAGNO, Danielle Queiroz"
Agora exibindo 1 - 3 de 3
- Resultados por página
- Opções de Ordenação
Item Acesso aberto (Open Access) Avaliação da atividade citotóxica e anti-invasiva da biflorina em linhagens de câncer gástrico do tipo intestinal(Universidade Federal do Pará, 2019-12-03) MOTA, Elizangela Rodrigues da Silva; CALCAGNO, Danielle Queiroz; http://lattes.cnpq.br/1326603355062154; https://orcid.org/0000-0002-4429-2573Natural products are sources of secondary metabolites with wide pharmacological applicability, including anticancer. Biflorin, a prenylated ortho-naphthoquinone that has been isolated from the roots of the Capraria biflora L. plant, has stood out as a potent prototype antitumor drug. However, despite promising potential, its antineoplastic capacity is incipiently applied to gastric cancer, one of the most incidente, aggressive and lethal cancers, nationally and globally. In this context, this study aimed to analyze the structure-toxicity relationship of biflorin by the redox in silico mechanism, as well as the in vitro cytotoxic and anti-invasive potential, using as a model strains of intestinal-type gastric adenocarcinoma metastatic (AGP01) and isolated from primary tumor (ACP03). In silico analysis showed that biflorin has a differentiated reactivity characteristic and can act as electron donor or acceptor in nucleophilic and electrophilic reactions, respectively. Moreover, when compared to other natural naphthoquinones such as β-lapachone and lapachol, it presented better redox properties and reactivity conditions, but with less toxic effect due to their ability to form more stable intermediates. The molecular simplification of biflorin also allowed to infer that the ortho-naphthoquinone functional group is probably the most related to naphthoquinones toxicity. Additionally, biflorin showed cytotoxic activity at considerably low concentrations for both strains, however, cytotoxicity was more pronounced for AGP01 (IC50 3.1 μM) compared to ACP03 (IC50 4.5 μM) at 48h treatment. Regarding antimetastatic activity, biflorin reduced the cell invasion capacity of the AGP01 strain only (p <0.0001). The results indicate that biflorin has cytotoxic activity for both gastric cancer strains AGP01 and ACP03, as well as anti-invasive specifically for metastatic cells AGP01. In addition, it was possible to clarify the probable selective cytotoxicity of biflorin based on its structural reactivity.Item Acesso aberto (Open Access) Avaliação do efeito do OTSSP167 em linhagens de adenocarcinoma gástrico com amplificação do gene MELK(Universidade Federal do Pará, 2019-12-09) PINHEIRO, Thayanne Macedo; CALCAGNO, Danielle Queiroz; http://lattes.cnpq.br/1326603355062154; https://orcid.org/0000-0002-4429-2573Gastric cancer is considered the fifth most common type of tumor in the world, and due to its heterogeneity, it is necessary to use individualized therapies that present less toxicity and greater efficacy during treatment. In a previous study, our group reported an increased copy number of the MELK gene in approximately 55.9% of tumors in patients with gastric adenocarcinoma and such tumor cell lines. This gene encodes maternal embryonic leucine zipper kinase (MELK) protein, a member of the serine/threonine kinase family, which participates in multiple cellular processes including cell cycle progression, cell proliferation, apoptosis, cell migration, and others. The increased expression has been observed in different cancers, including gastric cancer. Thus, the present study evaluated by in silico analysis the pharmacokinetic and pharmacodynamic properties of OTSSP167, its antineoplastic activity in gastric cancer cell lines ACP03 and AGP01, analyzing cell viability, the interference of this inhibitor in the protein expression of MELK in lineages, the ability of cell invasion and migration. In silico analyses, OTSSP167 showed a high probability of intestinal absorption, grade III toxicity and higher activity score for kinase inhibition. In vitro experiments, OTSSP167 showed cytotoxic activity in gastric strains, with higher cytotoxic activity against ACP03 (IC50 = 8.5nM). Also, this inhibitor was able to reduce MELK expression in ACP03 and AGP01 strains gradually according to the concentration of the compound. Regarding migration capacity, OTSSP167 was able to significantly inhibit the migration of ACP03 cells treated for 12 hours with three different concentrations of compound (4.25nM, 8.5nM, and 17nM), but in the 24-hour analyzes, there was only significance. OTSSP167 8.5nM and 17nM concentrations. However, the evaluation of cell invasion capacity after treatment with OTSSP167 for 48 hours did not yield significant statistical results. Thus, the results suggest that OTSSP167 has antineoplastic activity in lines with MELK gene amplification and inhibits cell migration capacity. Therefore, OTSSP167 has potential applicability in future therapies, requiring additional tests to delimit the mechanism of action of the compound.Item Acesso aberto (Open Access) Estabelecimento e caracterização citogenética de linhagem celular de carcinoma adenoide cístico(Universidade Federal do Pará, 2019-12-16) SILVA, Fernanda Jardim da; CALCAGNO, Danielle Queiroz; http://lattes.cnpq.br/1326603355062154; https://orcid.org/0000-0002-4429-2573Adenoid cystic carcinoma (ACC) is a rare neoplasm that mainly affects the head and neck regions, especially salivary glands. Growth is slow, but with but with a propensity to perineural invasion, local postoperative recurrence and metastasis. The most used treatment for this type of tumor is surgery followed by postoperative radiotherapy. The molecular characteristics of ACC are unclear, and unfortunately, the rarity of this type tumor limits to obtain in vitro and in vivo models that contribute in the investigation of pathogenesis and more efficient treatments. In the present study, a cell line was established and characterized for the evaluation of anticancer molecules. For this, it was obtained tissue samples of ACC off the tubular histological subtype from the retromolar trigone and a blood sample from a 59-year-old female patient. Array Comparative Genomic Hybridization (aCGH) performed molecular cytogenetic characterization in tumor tissue and cell line, while blood was genotyped for ancestry. Cell culture established from the collected tumor tissue showed rapid growth of tumor colonies from passage 18, stabilizing at passage 30. Blood genotyping revealed an ancestral contribution of 19% Amerindians, 31.5% Europeans and 49.5% of blacks. In cytogenetic analysis, gains were observed in loci harboring important genes such as EGFR (7p22.1-p11.2), BRAF (7q32.3-q34), HER2 (17q12-q21.2) and SMARCA1 (xq25-q27.1). Also in the lineage, loss (6q23.3-q25.1, PLAGL1 gene locus) and deletion (9p21.3-p21.1, CDKN2A/B gene locus) were observed; In tissue, only gains were observed (9q34.3, NOTCH1 locus and 5q32, PDGFRβ locus). The loss in 19p13.3-p12, locus of the CDKN2D gene, stands out as a common event in both samples. These findings corroborate other studies in the literature and make the established lineage a good in vitro model that can assist in the investigation of the pathogenesis of CAC and the basic research for new therapeutic modalities.